Abstract:Importance: Prior studies have demonstrated lower all-cause mortality in individuals who are overweight compared with those with normal body mass index (BMI), but whether this may come at the cost of greater burden of cardiovascular disease (CVD) is unknown.Objective: To calculate lifetime risk estimates of incident CVD and subtypes of CVD and to estimate years lived with and without CVD by weight status.Design, Setting, and Participants: In this population-based study, we used pooled individual-level data from adults (baseline age, 20-39, 40-59, and 60-79 years) across 10 large US prospective cohorts, with 3.2 million person-years of follow-up from 1964 to 2015. All participants were free of clinical CVD at baseline with available BMI index and CVD outcomes data. Data were analyzed from October 2016 to July 2017.Exposures: World Health Organization-standardized BMI categories.Main Outcomes and Measures: Total CVD and CVD subtype, including fatal and nonfatal coronary heart disease, stroke, congestive heart failure, and other CVD deaths. Heights and weights were measured directly by investigators in each study, and BMI was calculated as weight in kilograms divided by height in meters squared. We performed (1) modified Kaplan-Meier analysis to estimate lifetime risks, (2) adjusted competing Cox models to estimate joint cumulative risks for CVD or noncardiovascular death, and (3) the Irwin restricted mean to estimate years lived free of and with CVD.Results: Of the 190 672 in-person examinations included in this study, the mean (SD) age was 46.0 (15.0) years for men and 58.7 (12.9) years for women, and 140 835 patients (73.9%) were female. Compared with individuals with a normal BMI (defined as a BMI of 18.5 to 24.9), lifetime risks for incident CVD were higher in middle-aged adults in the overweight and obese groups. Compared with normal weight, among middle-aged men and women, competing hazard ratios for incident CVD were 1.21 (95% CI, 1.14-1.28) and 1.32 (95% CI, 1.24-1.40), respectively, for overweight (BMI, 25.0-29.9), 1.67 (95% CI, 1.55-1.79) and 1.85 (95% CI, 1.72-1.99) for obesity (BMI, 30.0-39.9), and 3.14 (95% CI, 2.48-3.97) and 2.53 (95% CI, 2.20-2.91) for morbid obesity (BMI, ≥40.0). Higher BMI had the strongest association with incident heart failure among CVD subtypes. Average years lived with CVD were longer for middle-aged adults in the overweight and obese groups compared with adults in the normal BMI group. Similar patterns were observed in younger and older adults.Conclusions and Relevance: In this study, obesity was associated with shorter longevity and significantly increased risk of cardiovascular morbidity and mortality compared with normal BMI. Despite similar longevity compared with normal BMI, overweight was associated with significantly increased risk of developing CVD at an earlier age, resulting in a greater proportion of life lived with CVD morbidity.

Long-Term Body Mass Index Variability and Adverse Cardiovascular Outcomes

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity

Longitudinal trajectories of BMI and cardiovascular disease risk: The national longitudinal study of adolescent health

Association of Long-Term Body Weight Variability with Dementia: a Prospective Study

High Variability of Body Mass Index Is Independently Associated With Incident Heart Failure

Longitudinal Body Weight Dynamics in Relation to Cognitive Decline over 18 Years: A Prospective Cohort Study

The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts

The Association of Long-Term Body Mass Index Variability with the Development of HFpEF and HFrEF Across Patterns of Weight Change

Longitudinal Body Weight Dynamics in Relation to Cognitive Decline over Two Decades: A Prospective Cohort Study.

Associations of variability in body mass index with cardiovascular outcomes in the general population: A systematic review

THE ASSOCIATION OF LONG-TERM TRAJECTORIES OF BMI, ITS VARIABILITY, AND METABOLIC SYNDROME: A 30-YEAR PROSPECTIVE COHORT STUDY

Variability of body mass index and risks of prostate, lung, colon, and ovarian cancers

BMI variability and cardiovascular outcomes within clinical trial and real-world environments in type 2 diabetes: an IMI2 SOPHIA study

Association of variability in body size with neuroimaging metrics of brain health: a population-based cohort study

Body Weight Change, All-Cause Mortality, and Cause-specific Mortality in the Multiple Risk Factor Intervention Trial

Body mass index trajectories in early life is predictive of cardiometabolic risk

Association and Time-Varying Effects of Body Mass Index on All-Cause Mortality in Patients With Hypertension

Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetes

Dynamic Features of Body Mass Index in Late Life Predict Cognitive Trajectories and Alzheimer's Disease: A Longitudinal Study

Body-Weight Fluctuations and Outcomes in Coronary Disease

Long-term variability in physiological measures in relation to mortality and epigenetic aging: prospective studies in the USA and China